Bristol-Myers Squibb
BMY
#197
Rank
S$147.18 B
Marketcap
S$72.08
Share price
0.67%
Change (1 day)
27.64%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): S$4.57

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$4.52. In 2025 the company made an earnings per share (EPS) of S$4.39 an increase over its 2024 EPS that were of S-$5.61.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.574.03%
2025S$4.39-178.28%
2024S-$5.61-213.92%
2023S$4.9330.2%
2022S$3.78-6.04%
2021S$4.03-179.29%
2020S-$5.08-281.37%
2019S$2.80-27.21%
2018S$3.85
2016S$3.39175.26%
2015S$1.23-19.83%
2014S$1.54-22.44%
2013S$1.9834.48%
2012S$1.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.09 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.91 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.66-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.61-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.83 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.38 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.25-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$11.87 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.52-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.82 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK